Hotels, gyms and restaurants carry highest COVID-19 spread risk, new study says
November 11, 2020Research and Development COVID, coronavirus
Reopening hotels, gyms and restaurants carries the highest risk of spreading coronavirus, according to a new study.
Pharmafile.com’s weekly COVID-19 news round-up
November 11, 2020Research and Development
The COVID-19 news this week focuses on vaccines, with AstraZeneca committing to an agreement to deliver 22 million doses of …
Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis
November 10, 2020Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …
NICE recommends venetoclax combo, a non-chemo option for untreated chronic lymphocytic leukaemia
November 10, 2020Manufacturing and Production, Sales and Marketing AbbVie, NHS, NICE, UK, leukaemia, venetoclax
NICE has recommended venetoclax in combination with obinutuzumab under final draft guidance for the first-line treatment of untreated chronic lymphocytic …
Scottish Medicines Consortium greenlights Nubeqa for prostate cancer
November 10, 2020Manufacturing and Production, Sales and Marketing
The Scottish Medicines Consortium has approved Nubeqa for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC) who are …
FDA grants Emergency Use Authorization to Eli Lilly’s antibody drug to treat COVID-19
November 10, 2020Manufacturing and Production
The FDA has granted Emergency Use Authorization (EUA) to Eli Lilly’s antibody drug bamlanivimab for the treatment of COVID-19 patients …
Sinovac COVID-19 trial suspended in Brazil due to severe adverse event
November 10, 2020Manufacturing and Production Brazil, COVID, COVID Vaccine, coronavirus
Brazil’s health regulator Anvisa has suspended a clinical trial for China’s Sinovac coronavirus vaccine due to the occurrence of a …
Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni
November 9, 2020Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine
AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …
AstraZeneca’s Brilinta combo reduces rate of disabling stroke or death in stroke patients, according to Phase 3 data
November 9, 2020Research and Development, Sales and Marketing AstraZeneca, Brilinta, pharma
AstraZeneca has unveiled new Phase 3 data for Brilinta (ticagrelor) as a treatment for patients who have suffered an acute …
Head of UK’s COVID-19 vaccine taskforce faces questions over biotech fund
November 9, 2020Sales and Marketing COVID, COVID-19, vaccines
Kate Bingham, the head of the British Government’s vaccine taskforce, faces scrutiny after it was revealed her venture capital firm …
FDA approves Nightware app on Apple Watch to treat sleep disturbances
November 9, 2020Sales and Marketing
The FDA has authorised the marketing of Nightware, a digital therapeutic application for the Apple Watch, in treating sleep disturbances. …
Viiv Healthcare’s cabotegravir effective in HIV prevention in women
November 9, 2020Sales and Marketing AIDS, HIV
Viiv Healthcare’s cabotegravir is more effective in preventing HIV in women than the oral standard of care, according to an …
China approves Astellas’ Xtandi in non-metastatic castration-resistant prostate cancer
November 6, 2020Medical Communications, Sales and Marketing Astellas, China, NMPA, Xtandi
China’s drug regulator, the National Medical Products Administration (NMPA), has given the green light to Astellas to market Xtandi (enzalutamide …
Johnson & Johnson and three drug distributors close to $26 billion settlement
November 6, 2020Medical Communications
Johnson & Johnson, McKesson, Cardinal Health and AmerisourceBergen are close to a $26 billion deal with local and state governments …
US Department of Justice looking into Pfizer’s operations in China
November 6, 2020Medical Communications
The US Department of Justice and the US Securities and Exchange Commission (SEC) are investigating Pfizer’s operations in China after …
Novartis’ arthritis therapy shows no efficacy in hospitalised COVID-19 patients
November 6, 2020Medical Communications, Research and Development COVID-19, Novatis, canakinumab
Novartis has revealed that its arthritis drug, theinterleukin-1 beta inhibitor canakinumab, in combination with standard of care (SoC), failed to …
Pharmafile.com’s weekly COVID-19 news round-up
November 6, 2020Medical Communications COVID, COVID-19, EC, FDA, coronavirus
The top ten news stories this week focus on regulatory approvals as the European Commission has approved GlaxoSmithKline’s Zeljula as …
Australia secures a further 50m COVID-19 vaccine doses from Novavax and Pfizer/BioNTech
November 5, 2020Manufacturing and Production Australia, COVID-19, Vaccine
Two more COVID-19 vaccine distribution deals have been signed by the Australian Government, reserving a further 50 million doses to …
Biogen’s Alzheimer’s drug expected to be approved by the FDA after successful late-stage trial
November 5, 2020Business Services
Biogen’s Alzheimer’s drug aducanumab is on track to be approved by the FDA after a successful late-stage clinical trial. The …
NICE shoots down Bristol-Myers Squibb immunotherapy Opdivo for post-surgery skin cancer
November 5, 2020Sales and Marketing BMS, Cancer, NHS, NICE, opdivo
NICE has rejected the routine use of Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) on the NHS in England and Wales for …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
